CMed Aesthetics is proud to announce a major milestone in its journey: our first injectable has officially achieved CE marking, marking the beginning of a new chapter in our commitment to advancing the future of aesthetic medicine.
This achievement represents far more than a regulatory milestone. It reflects our commitment to scientific rigor, regulatory compliance and continuous innovation, with the aim of developing solutions designed to meet the evolving needs of aesthetic medicine professionals.
Achieving CE marking for an injectable developed using NTS sterilization technology involved additional steps and a particularly demanding regulatory journey.
At CMed Aesthetics, we chose to embrace this challenge with a clear vision: to explore new approaches, invest in scientific development and continue raising the standards of quality and safety in aesthetic medicine.
We believe that meaningful progress comes from the willingness to innovate, from scientific rigor and from the pursuit of solutions that can contribute to the evolution of the field.
This milestone therefore represents not the conclusion of a journey, but the beginning of a new chapter for CMed Aesthetics.
With this milestone achieved, we are preparing to introduce our first injectable to the aesthetic medicine community.
What makes this new product different?
What inspired its development?
And what could it bring to the daily practice of aesthetic medicine professionals?
To provide the best experiences, we use technologies such as cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent may adversely affect certain features and functions.

